NL-OMON32905已完成不适用
A combined Single and Multiple Rising Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of SCH900062 in Healthy Adult Volunteers - SCH900062 FIH study
Schering-Plough0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Males and females
- •Between 30-60 years of age
排除标准
- •Clinical significant abnormalities for medical examination
研究者
相似试验
已完成
1 期
Phase 1 study of BAY 3283142 in Japanese healthy male participantsChronic kidney diseaseJPRN-jRCT2071230002Myoishi Masafumi36
招募中
1 期
A Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of SZN-043, a Novel Bispecific Fusion Protein Targeting ASGR1 and ZNRF3/RNF43, in Healthy Volunteers and Subjects with Liver CirrhosisAlcoholic HepatitisInflammatory and Immune System - Other inflammatory or immune system disordersLiver CirrhosisACTRN12622000392763Surrozen Operating, Inc.40
已完成
1 期
A study in healthy subjects to see the effects of the test medicine ALKS 2680 in single and multi-dose regimePhase 1 drug studyNervous System DiseasesISRCTN98204977Alkermes (United States)147
招募中
1 期
Single and multiple ascending dose study of oral ZKN-0013 or placebo given randomly to healthy volunteers to evaluate the safety, tolerability and the amount of drug in the body after drug administration.DermatologySkin - Dermatological conditionsHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12624000632594Eloxx Pharmaceuticals (AUS) Pty Ltd112
已完成
不适用
Evaluation of biomarkers for JAK inhibitorKCT0005706Seoul National University Hospital8